Clinical evaluation of thromboplastins manufactured by RENAM (Moscow) with international index of sensitivity (IIS) 1.1-1.5 and comparison of the results with the data obtained in the same patients with foreign thromboplastins (Dade, USA; Behring, Germany; Diamed, Switzerland) and Mediolab thromboplastins (Russia) manufactured from different raw materials (rabbit brain and human placenta) showed that by sensitivity to indirect anticoagulants, Russian thromboplastins made by RENAM and Mediolab firms are not inferior to the best foreign analogs.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
thromboplastins
5
[use domestic
4
domestic thromboplastins
4
thromboplastins attested
4
attested international
4
international indices
4
indices sensitivity
4
sensitivity treatment
4
treatment thrombophilia]
4
thrombophilia] clinical
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!